Dr Taufiq Binjemain (primary sponsor), 2023-11-09: An Australian single-arm case series of the 19-item ReDO protocol, in which item 13 is mebendazole or fenbendazole 100 mg twice daily, with patients as their own controls and circulating tumour cells as the primary outcome.
13 Mebendazole / Fenbendazole 100 mg x2
Registry record field, intervention list (unpaginated)
Dr Taufiq Binjemain (primary sponsor), 2023-11-09: An Australian single-arm case series of the 19-item ReDO protocol, in which item 13 is mebendazole or fenbendazole 100 mg twice daily, with patients as their own controls and circulating tumour cells as the primary outcome. Study type: uncontrolled series.
